The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Gerold Bepler

H. Lee Moffitt Cancer Center and Research Institute

Tampa

FL 33612-9497

USA

[email]@moffitt.usf.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612-9497, USA. 2005 - 2006
  • Thoracic Oncology Program, Lee Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, USA. 2005
  • Thoracic Oncology Program, H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida, Tampa 33612, USA. 2003 - 2004
  • Lung Cancer Program, Roswell Park Cancer Institute, Buffalo, USA. 2002

References

  1. RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer. Bepler, G., Kusmartseva, I., Sharma, S., Gautam, A., Cantor, A., Sharma, A., Simon, G. J. Clin. Oncol. (2006) [Pubmed]
  2. Pharmacogenomics: a reality or still a promise?. Bepler, G. Lung. Cancer (2006) [Pubmed]
  3. Ribonucleotide reductase M1 gene promoter activity, polymorphisms, population frequencies, and clinical relevance. Bepler, G., Zheng, Z., Gautam, A., Sharma, S., Cantor, A., Sharma, A., Cress, W.D., Kim, Y.C., Rosell, R., McBride, C., Robinson, L., Sommers, E., Haura, E. Lung. Cancer (2005) [Pubmed]
  4. Using translational research to tailor the use of chemotherapy in the treatment of NSCLC. Bepler, G. Lung. Cancer (2005) [Pubmed]
  5. RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer. Bepler, G., Sharma, S., Cantor, A., Gautam, A., Haura, E., Simon, G., Sharma, A., Sommers, E., Robinson, L. J. Clin. Oncol. (2004) [Pubmed]
  6. A systematic review and lessons learned from early lung cancer detection trials using low-dose computed tomography of the chest. Bepler, G., Goodridge Carney, D., Djulbegovic, B., Clark, R.A., Tockman, M. Cancer. Control (2003) [Pubmed]
  7. Prognostic significance of molecular genetic aberrations on chromosome segment 11p15.5 in non-small-cell lung cancer. Bepler, G., Gautam, A., McIntyre, L.M., Beck, A.F., Chervinsky, D.S., Kim, Y.C., Pitterle, D.M., Hyland, A. J. Clin. Oncol. (2002) [Pubmed]
 
WikiGenes - Universities